Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Market Cap	90.00B +87.5%
Revenue (ttm)	152.40B +31.0%
Net Income	15.98B +112.9%
EPS	3,196.17 +112.9%
Shares Out	5.00M
PE Ratio	5.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,538
Average Volume	6,159
Open	18,200
Previous Close	18,700
Day's Range	18,000 - 18,200
52-Week Range	8,500 - 26,400
Beta	0.77
RSI	34.20
Earnings Date	Jul 17, 2026

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company produces and trades in veterinary medicines in Vietnam and Indochina. It offers products for cattle, pigs, chickens and ducks, dogs and cats, shrimp and fish, and other species. The company was formerly known as Cai Lay Livestock and Veterinary Pharmacy Company. Cai Lay Veterinary Pharmaceutical Joint Stock Company was incorporated in 2002 and is headquartered in Cai Lay town, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 112
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2025, HNX:MKV's revenue was 149.79 billion, an increase of 39.94% compared to the previous year's 107.04 billion. Earnings were 16.89 billion, an increase of 130.61%.